G. Gilcrease

The effect of breathing manner on inferior vena caval diameter.

B. J. Kimura, R. Dalugdugan, G. Gilcrease, J. N. Phan +2 more

2011European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology99 citations Open access

Semantic Scholar

G. Gilcrease

Most-cited papers

The effect of breathing manner on inferior vena caval diameter.

A Delayed Case of Fatal Atrioesophageal Fistula Following Radiofrequency Ablation for Atrial Fibrillation

Mental Health Disorders are More Common in Colorectal Cancer Survivors and Associated with Decreased Overall Survival

Diagnostic performance of a pocket-sized ultrasound device for quick-look cardiac imaging.

Clinical Activity of Selitrectinib in a Patient With Mammary Analogue Secretory Carcinoma of the Parotid Gland With Secondary Resistance to Entrectinib.

Design, Synthesis, and Biological Evaluation of a Series of Anthracene-9,10-dione Dioxime β-Catenin Pathway Inhibitors.

Phase I/II study of everolimus combined with mFOLFOX-6 and bevacizumab for first–line treatment of metastatic colorectal cancer

Fatal Statin-Induced Rhabdomyolysis by Possible Interaction with Palbociclib

Familial Risk in Patients With Carcinoma of Unknown Primary.

Discrepancies between tumor genomic profiling and germline genetic testing

A phase II study of apatinib, a highly selective inhibitor of VEGFR-2, in patients with metastatic solid tumors without standard treatment options

Pembroliuzmab in gastrointestinal (GI) malignancies with defective DNA mismatch repair (dMMR): A single institution experience.

Phase I study of mFOLFOX-6, bevacizumab, and mTOR inhibitor RAD001 as first-line treatment of metastatic colorectal cancer.

Survival of patients with metastatic HER2 positive gastro-oesophageal cancer treated with second-line chemotherapy plus trastuzumab or ramucirumab after progression on front-line chemotherapy plus trastuzumab

A phase I dose escalation trial to assess the safety and preliminary efficacy of mFOLFOX6 combined with pembrolizumab (MK3475) in advanced gastrointestinal malignancies

Comment on “Lung Transplantation for Elderly Patients With End-stage COVID–19 Pneumonia”

529MO Activity, safety and circulating tumour DNA (ctDNA) dynamics of paradox breaker BRAF inhibitor PLX8394 in patients with advanced cancer

Analysis of Nonsurgical Treatment Options for Metastatic Rectal Cancer.

(OA44) Mental Health Disorders are More Common in Colorectal Cancer Survivors and Associated With Decreased Overall Survival

Abstract 3592: Preclinical combination strategies for development of JI-101, a selective inhibitor of Ephrin B4, VEGF R2 and PDGF-Rβ

Phase I Study of Rivoceranib, a Selective VEGFR-2 Angiogenesis Inhibitor, Administered Daily in Patients With Advanced Solid Tumors

Survival of patients with metastatic HER2 positive gastroesophageal cancer treated with second-line chemotherapy plus trastuzumab or ramucirumab after progression on frontline chemotherapy plus trastuzumab.

Safety and Tolerability of Dose-Escalated, Hypofractionated Radiation Therapy in Combination with Losartan for Locally Advanced Pancreatic Cancer, a Phase I Prospective Clinical Trial

A phase I open-label study of the safety and efficacy of apatinib (rivoceranib) administered to patients with advanced malignancies to improve sensitivity to pembrolizumab in the second- or later-line setting (APPEASE)

645P A phase Ib dose escalation study of binimetinib plus mFOLFIRI in patients with metastatic RAS mutated colorectal cancer

Feasibility Of A Home-based, Remotely-supervised Exercise Intervention In Colorectal Cancer Survivors: A Pilot Study

Improving the diagnostic yield of biliary stricture biopsies using a directional atherectomy device.

Case series examining somatic test results for patients with hereditary cancer syndromes associated with gastrointestinal cancer risk.

452P A phase Ib dose escalation study of binimetinib plus mFOLFIRI in patients with metastatic RAS mutated colorectal cancer

Pembrolizumab in advanced gastrointestinal malignancies with defective dna mismatch repair: A case series

A phase 1 trial of a potent and selective VEGF receptor inhibitor, apatinib, in patients with advanced solid tumors.

Preclinical activity of BC2059, a novel compound that degrades beta-catenin, in colon cancer models.

LIMITATIONS IN USING COLLAPSE OF THE INFERIOR VENA CAVA TO ESTIMATE CENTRAL VENOUS PRESSURE: THE ROLE OF DIAPHRAGMATIC DESCENT

IMAGE QUALITY OF A NEW POCKET-SIZED ULTRASOUND DEVICE: IMPLICATIONS FOR BEDSIDE SUBJECTIVE CARDIAC DIAGNOSIS